As of Feb 05
| -0.17 / -7.17%|
The 2 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 9.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +309.09% increase from the last price of 2.20.
The current consensus among 3 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.